ENDRA Life Sciences (NDRA) Assets (2016 - 2026)

ENDRA Life Sciences (NDRA) has reported Assets for 11 consecutive years, with $7.9 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Assets rose 182.88% year-over-year to $7.9 million in Q2 2026; TTM through Jun 2026 was $7.9 million, a 182.88% increase from a year earlier, with the FY2025 full-year figure at $3.9 million, up 566.73% from the prior year.
• Assets was $7.9 million for Q2 2026 at ENDRA Life Sciences, up from $3.4 million in the prior quarter.
• Over five years, Assets peaked at $15.3 million in Q2 2022 and troughed at $229771.0 in Q3 2024.
• A 5-year average of $6.5 million and a median of $6.7 million in 2023 frame the typical range for Assets.
• Across the five-year window, Assets tumbled 96.98% in 2024 and surged 754.81% in 2025, its largest moves.
• Over 5 years, Assets stood at $9.3 million in 2022, then retreated by 27.17% to $6.8 million in 2023, then tumbled by 91.44% to $578013.0 in 2024, then surged by 566.73% to $3.9 million in 2025, then surged by 106.09% to $7.9 million in 2026.
• The last three Assets figures came in at $7.9 million (Q2 2026), $3.4 million (Q1 2026), and $3.9 million (Q4 2025), per Business Quant data.